Device for manufacturing cell-derived vesicles and manufacturing method using same
US-2024200008-A1 · Jun 20, 2024 · US
US9834792B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9834792-B2 |
| Application number | US-201514920862-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 22, 2015 |
| Priority date | Oct 22, 2014 |
| Publication date | Dec 5, 2017 |
| Grant date | Dec 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Multi-stage, biological processes and systems for converting a C1 carbon source to desired end products are described. The processes comprise dividing a gaseous C1-containing substrate, in parallel, among multiple bioreactor stages. Liquid products are successively fed, in series, from a first bioreactor stage to downstream bioreactor stages. Operation can be simplified by avoiding the requirement for microorganism separation and recycle at each stage. In addition, overall vapor-liquid mass transfer for the combined stages is very favorable, leading to high end product productivity with comparably low byproduct metabolite productivity.
Opening claim text (preview).
The invention claimed is: 1. A multi-stage process for converting C1 carbon source into an end product, the process comprising: feeding a gaseous C1-containing substrate, in parallel, to a first bioreactor stage and at least a second bioreactor stage of the multi-stage process, feeding at least a portion of a first stage liquid product, in series, from the first bioreactor stage to the second bioreactor stage, wherein the first stage liquid product comprises a C1-fixing microorganism used in the first bioreactor stage to metabolize C1-carbon source and generate the end product. 2. The process of claim 1 , wherein the first stage liquid product is fed to the second bioreactor stage, without separation of the C1-fixing microorganism and recycle of separated C1-fixing microorganism to the first bioreactor stage. 3. The process of claim 1 , comprising at least four bioreactor stages in which the gaseous C1-containing substrate is fed in parallel to the stages, and liquid products, including the first stage liquid product, are fed successively from the first bioreactor stage to a final bioreactor stage, and then withdrawn from the final bioreactor stage. 4. The process of claim 3 , wherein an overall C1 utilization of the at least four bioreactor stages is at least about 60%. 5. The process of claim 3 , wherein the at least four bioreactor stages are operated at a pressure of less than about 200 kilopascal (kPa) above atmospheric pressure. 6. The process of claim 1 , wherein the end product is ethanol and, in addition to ethanol, the C1-fixing microorganism generates acetic acid as a metabolite. 7. The process of claim 6 , further comprising withdrawing a final stage liquid product from a final bioreactor stage of the multi-stage process, wherein a biomass free liquid fraction of the final stage liquid product comprises at least about 50 grams per liter (g/l) of ethanol. 8. The process of claim 7 , wherein the biomass free liquid fraction of the final stage liquid product has an ethanol:acetic acid weight ratio of at least about 50:1. 9. The process of claim 1 , wherein the end product is a growth dependent product selected from the group consisting of isopropanol, butanol, acetate, acetone, 2-hydroxyisobutyric acid and isobutylene. 10. The process of claim 9 , further comprising withdrawing a final stage liquid product from a final bioreactor stage of the multi-stage process, wherein a biomass free liquid fraction of the final stage liquid product comprises at least about 10 grams per liter (g/l) of isopropanol. 11. The process of claim 1 , wherein the first and second bioreactor stages have at least one independently controllable process operating variable selected from the group consisting of liquid culture medium addition rate, gaseous C1-containing substrate feed rate, reactor temperature, reactor pH, and combinations thereof. 12. The process of claim 1 , wherein at least one of the first and second bioreactor stages comprises a bioreactor having a ratio of its length to its width of less than about 10:1. 13. The process of claim 1 , wherein at least one of the first and second bioreactor stages comprises a circulated loop bioreactor. 14. The process of claim 13 , wherein the circulated loop bioreactor operates with internal liquid circulation in a continuous liquid phase zone. 15. The process of claim 14 , wherein, in the continuous liquid phase zone, liquid flows upward in an internal riser and downward in one or more internal downcomers. 16. The process of claim 14 , wherein the circulated loop bioreactor operates with countercurrent gas and liquid flows in a continuous vapor phase zone, above the continuous liquid phase zone. 17. The process of claim 16 , wherein the continuous liquid phase zone is within a bottom 75% of the length of the circulated loop bioreactor. 18. The process of claim 16 , wherein the continuous liquid phase zone and continuous gas phase zone comprise vapor-liquid contacting devices, wherein continuous liquid phase zone devices differ from continuous vapor phase zone devices. 19. The process of claim 16 , wherein liquid product, recycled through an external recycle loop, is to the continuous vapor phase zone. 20. The process of claim 19 , wherein the liquid product that is recycled through the external recycle loop, is passed through an external heat exchanger for control of the temperature of the circulated loop bioreactor. 21. The process of claim 19 , wherein a basic neutralizing agent is added to the liquid product that is recycled through the external recycle loop, to control the pH of the circulated loop bioreactor. 22. A multi-stage, biological process for converting CO to ethanol, the process comprising: dividing a gaseous CO-containing substrate, in parallel, among a plurality of bioreactor stages of the multi-stage process; successively feeding liquid products comprising carboxydotrophic microorganism, in series, from a first bioreactor stage to downstream bioreactor stages, withdrawing, from a final bioreactor stage, a final stage liquid product having a non-carboxydotrophic microorganism containing liquid fraction comprising at least about 50 grams per liter (g/l) of ethanol and having an ethanol : acetic acid weight ratio of at least about 50:1. 23. The process of claim 22 , comprising at least four bioreactor stages. 24. The process of claim 22 , wherein two or more of the plurality of bioreactor stages are separate sections within a single vessel.
Reaction vessels connected in series or in parallel (combinations of bioreactors with other apparatus, C12M43/00) · CPC title
polyhydric · CPC title
Multiple stages of fermentation; Multiple types of microorganisms or re-use of microorganisms · CPC title
acyclic · CPC title
Acetic acid (vinegar C12J) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.